Contact Us

Antitope Ltd
Babraham Research Campus
Babraham
Cambridge CB22 3AT
United Kingdom

Telephone: +44(0) 1223 496190
Fax: +44(0) 1223 496191
Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

PolyTherics Ltd
The London Bioscience Innovation Centre
2 Royal College Street
London NW1 0NH
United Kingdom

Telephone: +44 (0)20 7691 4927
Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

2012

 
05.11.2012
Antitope Develops New Biologic For Treatment of Multiple Sclerosis
Antitope Ltd (Cambridge, UK), today announced the development of a new potential treatment for multiple sclerosis (MS). The biologic, named ANT2034, is an antibody which targets CD52 on the surface of lymphocytes and was developed using Antitope's Composite Human Antibody™ technology....
22.05.2012
Meet Antitope at BIO International Convention 2012 (Boston, MA, USA 18th – 22nd June)
Antitope will be participating in the Business Partnering Forum at the BIO International Convention and welcome the opportunity to discuss potential collaborations with companies that are interested in assessing and/or removing immunogenicity from protein therapeutics. Meetings can be arranged...
22.05.2012
Antitope, Prothix, Bioceros, and University Medical Center Utrecht awarded Eurostars grant
Dutch Biotech companies Prothix BV and Bioceros BV, University Medical Center Utrecht (UMCU, the Netherlands) and UK biotech company Antitope Ltd. announce that they have been awarded a grant within Eureka’s Eurostars™ program with a total budget of over €1.6 million for the...
21.02.2012
Antitope announces the launch of new Composite CHO technology for development of manufacturing cell lines suitable for biologics
Antitope today announced the launch of Composite CHO technology for the generation of CHO cell lines suitable for cGMP manufacture of recombinant antibodies and proteins.  The Composite CHO technology has been developed for direct transfer of genes into CHO cells pre-adapted to grow in...